(Total Views: 525)
Posted On: 03/06/2021 1:28:22 AM
Post# of 153898
Are we expecting s/c data for day 42? Is the FDA motivated by deaths, to give leronlimab full FDA approval?
Only 11% of critical patients given SOC, had left the hospital alive and cured, at or before day 28.
Let's say another 35% of the critical patients who got SOC had died by day 28.
That leaves 54% who at day 28, were still in the hospital being treated with SOC.
Those 54%, some of them, maybe 35 to 70% of them, died after day 28. Maybe very few or none of the critical who got LL died after day 28.
Is 42 day data substantially improved vs 28 day data? Will 42 day data be considered?
Only 11% of critical patients given SOC, had left the hospital alive and cured, at or before day 28.
Let's say another 35% of the critical patients who got SOC had died by day 28.
That leaves 54% who at day 28, were still in the hospital being treated with SOC.
Those 54%, some of them, maybe 35 to 70% of them, died after day 28. Maybe very few or none of the critical who got LL died after day 28.
Is 42 day data substantially improved vs 28 day data? Will 42 day data be considered?
(2)
(0)
